ArticleBreast cancer (Tokyo, Japan)2026

Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score

Kei Koizumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.